Recombinant ASFV p72 complex(Cat. No.:DRA162) novoprotein
$50.00
In stock
SKU
DRA162
50μg: Inquiry
500μg: Inquiry
1mg: Inquiry
Description
Recombinant ASFV p72 complex is produced by our Mammalian expression system and the target gene encoding Met1-Thr646&Met1-Leu530 is expressed with a 10His-3*Flag tag and a Flag-Strep tag at the N-terminus.
Product Details
| Item | Details |
| Known As | BA71V-B646L (P72); PB646L; BA71V-B646L (p72); B646L |
| Mol Mass | 77.6&64 kDa |
| APMol Mass | 75-85&65-70 kDa, reducing conditions |
| Formulation Description | Supplied as a 0.2 μm filtered solution of 50mM HEPES，150mM NaCl，10% Glycerol，0.06% DDM，0.012% CHS，pH8.0. |
| Purity-SDS-PAGE | Bioactivity Special bioactivity ELISA 70%-130% |
| Shipping | The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below. |
| Storage | Reconstituted protein solution should be stored at ≤ -70°C. Stable for at least 24 months when stored as instructed. |
Background
African swine fever (ASF) is a highly contagious hemorrhagic viral disease of domestic and wild pigs that is responsible for serious economic and production losses. It is caused by the African swine fever virus (ASFV), a large and complex icosahedral DNA virus of the Asfarviridae family. Protein p72 is the major capsid protein of African swine fever virus (ASFV) and is an important target for test and vaccine development. Previous studies showed that p72 is a major antigen in infected pigs and is widely used as a marker for diagnosis of infection.
title: Recombinant vaccinia vectored ASFV vaccine enhances swine survival against genotype II challenge
authors: Dong Lanlan, Gao Nan, Liu Renqiang, Cao Kangli, Xia Ai, Yang Tianhan, Pan Xinghao, Zhu Cuisong, Zhang Ziling, Zhao Dongming, Zhao Chen, Zhang Xiaoyan, Xu Jianqing
date: 2026/01/23
journal: npj Vaccines
MDSD
Reviews
Write Your Own Review
Related Products
Check items to add to the cart or
